Description: With Parkinson’s continuing to prevail as a neurodegenerative disorder with no cure and invasive, expensive, and inaccessible diagnostics, there is a significant need for a convenient solution. We propose SynTest, the only clinical-grade, at-home, and noninvasive test in the market designed to detect Parkinson’s biomarkers through a simple application of spit onto our multiplex testing strip. Through nano-particle-based technology coupled with colorimetric sensors analyzed via our state-of-the-art algorithms in a custom app, Parkinson’s testing has never been easier – cheap, simple, and in the comfort of your home.
The problem we are addressing: Every 6 minutes, a person in the United States gets diagnosed with Parkinson's. With a steadily increasing disease rate and over a million patients nationwide, early diagnosis is crucial for improving outcomes and slowing progression – with current diagnoses only made after motor symptoms begin to appear, leading to irreversible damage and a significant amount of lost time. As a result, people suffering from neurodegenerative symptoms are having to delay their testing because of the lack of preventative care and invasive, costly, and complex diagnostic methods like cerebrospinal fluid analyses and neuroimaging available today.
